Ticker: PULM

Pulmatrix, Inc. (NASDAQ: PULM) is a biopharmaceutical company focused on developing inhaled therapeutic products for migraine and respiratory diseases using its patented iSPERSE™ technology. As of June 30, 2025, the company reported several key financial metrics. Revenues: No revenue reported fo...